For: | Nimer A, M P, D G, Y B, G S. Clinical implication of VEGF serum levels in cirrhotic patients with or without portal hypertension. World J Gastroenterol 1999; 5(4): 296-300 [PMID: 11819451 DOI: 10.3748/wjg.v5.i4.296] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v5/i4/296.htm |
Number | Citing Articles |
1 |
Eugenio Gaudio, Barbara Barbaro, Domenico Alvaro, Shannon Glaser, Heather Francis, Antonio Franchitto, Paolo Onori, Yoshiyuki Ueno, Marco Marzioni, Giammarco Fava, Julie Venter, Ramona Reichenbach, Ryun Summers, Gianfranco Alpini. Administration of r-VEGF-A prevents hepatic artery ligation-induced bile duct damage in bile duct ligated rats. American Journal of Physiology-Gastrointestinal and Liver Physiology 2006; 291(2): G307 doi: 10.1152/ajpgi.00507.2005
|
2 |
Alexandr S. Ivanov, Irina V. Garmasch, Olga S. Arisheva, Mariya A. Markova, Anna S. Melnik, Natalya N. Terebilina, Valeria Yu. Baronets, Daniil I. Peregud, Ekaterina V. Tarasenko, Zhanna D. Kobalava. Association of SNPs in the Promoter Regions of VEGF (rs699947 и rs2010963), ICAM1 (rs281437) and ET-1 (rs1800541) with Serum Levels of Related Proteins and Alcoholic Liver Cirrhosis Risk. Annals of the Russian academy of medical sciences 2018; 73(6): 368 doi: 10.15690/vramn1059
|
3 |
Muttiah Barathan, Behnaz Riazalhosseini, Thevambiga Iyadorai, Kumutha Malar Vellasamy, Jamuna Vadivelu, Li-Yen Chang, Ahmad Khusairy Zulpa, Marie Larsson, Esaki M. Shankar, Rosmawati Mohamed. Comparative expression of pro-inflammatory and apoptotic biosignatures in chronic HBV-infected patients with and without liver cirrhosis. Microbial Pathogenesis 2021; 161: 105231 doi: 10.1016/j.micpath.2021.105231
|